{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:50:10Z","timestamp":1789206610536,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"crossref","award":["108712"],"award-info":[{"award-number":["108712"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Erlangen"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.bcp.2011.11.022","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T11:15:48Z","timestamp":1323342948000},"page":"480-488","source":"Crossref","is-referenced-by-count":44,"title":["Akt and p53 are potential mediators of reduced mammary tumor growth by Chloroquine and the mTOR inhibitor RAD001"],"prefix":"10.1016","volume":"83","author":[{"given":"Christian R.","family":"Loehberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Strissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Dittrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Strick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Dittmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dittmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Fabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willi A.","family":"Kalender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Wachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Groh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Polier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentine","family":"Koppitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Oeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Fasching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Lux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias W.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Schrauder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2011.11.022_bib0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.270.5233.50","article-title":"PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints","volume":"270","author":"Keith","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bcp.2011.11.022_bib0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0092-8674(00)00117-3","article-title":"TOR, a central controller of cell growth","volume":"103","author":"Schmelzle","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2011.11.022_bib0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc1362","article-title":"The TOR pathway: a target for cancer therapy","volume":"4","author":"Bjornsti","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2011.11.022_bib0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.11.022_bib0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-5793(97)00323-2","article-title":"The modular phosphorylation and activation of p70s6k","volume":"410","author":"Pullen","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2011.11.022_bib0030","doi-asserted-by":"crossref","first-page":"16621","DOI":"10.1074\/jbc.273.26.16621","article-title":"Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies","volume":"273","author":"Weng","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.11.022_bib0035","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1200\/JCO.2007.14.0988","article-title":"Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors","volume":"26","author":"O\u2019Donnell","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0040","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O\u2019Reilly","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.022_bib0045","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1158\/0008-5472.CAN-05-0917","article-title":"Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition","volume":"65","author":"Sun","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.022_bib0050","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1200\/JCO.2007.14.5482","article-title":"Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors","volume":"26","author":"Tabernero","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0055","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1471-4892(03)00071-7","article-title":"Targeting mTOR signaling for cancer therapy","volume":"3","author":"Huang","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0060","article-title":"Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism","author":"Wan","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2011.11.022_bib0065","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/1535-7163.MCT-08-0668","article-title":"Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K\/mTOR inhibition","volume":"8","author":"Breuleux","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.11.022_bib0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ceb.2005.02.008","article-title":"The expanding TOR signaling network","volume":"17","author":"Martin","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0075","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1158\/0008-5472.CAN-08-1522","article-title":"Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR\/raptor inhibition-initiated, mTOR\/rictor-independent Akt activation","volume":"68","author":"Wang","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.022_bib0080","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1128\/MCB.25.6.2347-2363.2005","article-title":"Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation","volume":"25","author":"Scheid","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0085","doi-asserted-by":"crossref","first-page":"12026","DOI":"10.1158\/0008-5472.CAN-07-3058","article-title":"Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis","volume":"67","author":"Loehberg","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.022_bib0090","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.onc.1205181","article-title":"Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis","volume":"21","author":"Gottlieb","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2011.11.022_bib0095","doi-asserted-by":"crossref","first-page":"21843","DOI":"10.1074\/jbc.M109745200","article-title":"Akt enhances Mdm2-mediated ubiquitination and degradation of p53","volume":"277","author":"Ogawara","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.11.022_bib0100","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.1016\/j.bmc.2008.07.076","article-title":"The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine","volume":"16","author":"Hu","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bcp.2011.11.022_bib0105","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejmech.2009.11.017","article-title":"A 4-aminoquinoline derivative that markedly sensitizes tumor cell killing by Akt inhibitors with a minimum cytotoxicity to non-cancer cells","volume":"45","author":"Hu","year":"2010","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bcp.2011.11.022_bib0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3835(80)90097-X","article-title":"Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice","volume":"11","author":"Shafie","year":"1980","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2011.11.022_bib0115","doi-asserted-by":"crossref","first-page":"10657","DOI":"10.1073\/pnas.88.23.10657","article-title":"Mutations in p53 as potential molecular markers for human breast cancer","volume":"88","author":"Runnebaum","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.11.022_bib0120","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1128\/MCB.01184-07","article-title":"Key role for activin B in cellular transformation after loss of the von Hippel-Lindau tumor suppressor","volume":"29","author":"Wacker","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0125","doi-asserted-by":"crossref","first-page":"13121","DOI":"10.1074\/jbc.M109.087171","article-title":"Vinculin facilitates cell invasion into three-dimensional collagen matrices","volume":"285","author":"Mierke","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.11.022_bib0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2007.10.020","article-title":"PTHrP promotes homotypic aggregation of breast cancer cells in three-dimensional cultures","volume":"260","author":"Dittmer","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2011.11.022_bib0135","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1007\/s00018-009-0089-0","article-title":"Human mesenchymal stem cells induce E-cadherin degradation in breast carcinoma spheroids by activating ADAM10","volume":"66","author":"Dittmer","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bcp.2011.11.022_bib0140","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1210\/endo.139.4.5892","article-title":"Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089","volume":"139","author":"VanWeelden","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2011.11.022_bib0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1083\/jcb.200801099","article-title":"Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents","volume":"183","author":"Degtyarev","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0150","doi-asserted-by":"crossref","first-page":"8967","DOI":"10.1158\/0008-5472.CAN-09-2190","article-title":"Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy","volume":"69","author":"Fu","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.022_bib0155","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Bellodi","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2011.11.022_bib0160","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1002\/ijc.23900","article-title":"Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen","volume":"123","author":"Strissel","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2011.11.022_bib0165","first-page":"689","article-title":"Mesenchymal stem cells and carcinoma-associated fibroblasts sensitize breast cancer cells in 3D cultures to kinase inhibitors","volume":"39","author":"Dittmer","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0170","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1126\/science.8475385","article-title":"Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta","volume":"260","author":"Koff","year":"1993","journal-title":"Science"},{"issue":"Pt 2","key":"10.1016\/j.bcp.2011.11.022_bib0175","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1042\/bj3440427","article-title":"Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation","volume":"344","author":"Nave","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2011.11.022_bib0180","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1073\/pnas.89.9.4052","article-title":"A single gene encodes two isoforms of the p70 S6 kinase: activation upon mitogenic stimulation","volume":"89","author":"Reinhard","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.11.022_bib0185","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1200\/JCO.2008.18.8391","article-title":"Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer","volume":"27","author":"Baselga","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-0029-1185334","article-title":"Molekulare Mechanismen der Chemoresistenz und Moeglichkeiten der \u00dcberwindung","volume":"69","author":"Gluz","year":"2009","journal-title":"Geburtsh Frauenheilk"},{"key":"10.1016\/j.bcp.2011.11.022_bib0195","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1046\/j.1432-1327.2001.02225.x","article-title":"Post-translational modifications and activation of p53 by genotoxic stresses","volume":"268","author":"Appella","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2011.11.022_bib0200","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1101\/gad.914401","article-title":"Cell cycle checkpoint signaling through the ATM and ATR kinases","volume":"15","author":"Abraham","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2011.11.022_bib0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/35043058","article-title":"The many substrates and functions of ATM","volume":"1","author":"Kastan","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1535-6108(03)00048-5","article-title":"Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A","volume":"3","author":"Sorensen","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2011.11.022_bib0215","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/35071124","article-title":"The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis","volume":"410","author":"Falck","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.11.022_bib0220","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1083\/jcb.38.2.392","article-title":"Autophagic vacuoles produced in vitro. II. Studies on the mechanism of formation of autophagic vacuoles produced by chloroquine","volume":"38","author":"Fedorko","year":"1968","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0225","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrclinonc.2011.71","article-title":"Autophagy as a target for anticancer therapy","volume":"8","author":"Janku","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0169-4758(90)90215-P","article-title":"Chloroquine as intercalator: a hypothesis revived","volume":"6","author":"Meshnick","year":"1990","journal-title":"Parasitol Today"},{"key":"10.1016\/j.bcp.2011.11.022_bib0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0014-5793(95)00144-X","article-title":"Alterations in the internucleosomal DNA helical twist in chromatin of human erythroleukemia cells in vivo influences the chromatin higher-order folding","volume":"361","author":"Krajewski","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2011.11.022_bib0240","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/07391102.1999.10508318","article-title":"Effect of in vivo histone hyperacetylation on the state of chromatin fibers","volume":"16","author":"Krajewski","year":"1999","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bcp.2011.11.022_bib0245","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1023\/A:1011536423533","article-title":"Analysis of chromatin structural transitions by means of intercalator dyes","volume":"378","author":"Krajewski","year":"2001","journal-title":"Dokl Biochem Biophys"},{"key":"10.1016\/j.bcp.2011.11.022_bib0250","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1158\/1078-0432.CCR-06-2837","article-title":"Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency","volume":"13","author":"Lu","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.022_bib0255","doi-asserted-by":"crossref","first-page":"11381","DOI":"10.1158\/0008-5472.CAN-06-2316","article-title":"Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland","volume":"66","author":"Torres-Arzayus","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.11.022_bib0260","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/rheumatology\/36.7.799","article-title":"Antimalarial drugs in the treatment of rheumatological diseases","volume":"36","author":"Rynes","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.bcp.2011.11.022_bib0265","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1101\/gad.1061803","article-title":"In vitro propagation and transcriptional profiling of human mammary stem\/progenitor cells","volume":"17","author":"Dontu","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2011.11.022_bib0270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1014594825502","article-title":"Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant","volume":"19","author":"dit Faute","year":"2002","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.bcp.2011.11.022_bib0275","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ncb0901-785","article-title":"ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini","volume":"3","author":"Muthuswamy","year":"2001","journal-title":"Nat Cell Biol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211008598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211008598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T21:58:40Z","timestamp":1543355920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295211008598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0006295211008598"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2011.11.022","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}